Microbiological Quality and Resistance to an Artificial Gut Environment of Two Probiotic Formulations.

The quality control of probiotic products is the focus of numerous organizations worldwide. Several studies have highlighted the poor microbiological quality of many commercial probiotic formulations in terms of the identity of the contained microorganisms, viability, and purity, thus precluding the expected health benefits and representing a potential health risk for consumers. In this paper, we analyzed the contents of two probiotic formulations, one composed of an encapsulated mixture of lactobacilli and bifidobacteria, and one by a lyophilized yeast. The microorganisms contained in the products were quantified and identified using up-to-date methodologies, such as MALDI-TOF MS and metagenomic analysis. Moreover, as acid and bile tolerance is included among the criteria used to select probiotic microorganisms, in vitro tests were performed to evaluate the behavior of the formulations in conditions mimicking the harsh gastric environment and the intestinal fluids. Our results indicate the high quality of the formulations in terms of the enumeration and identification of the contained organisms, as well as the absence of contaminants. Moreover, both products tolerated the acidic conditions well, with encapsulation providing further protection for the microorganisms. A good tolerance to the simulated artificial intestinal conditions was also evidenced for both preparations.

A randomized trial of ethyl lauroyl arginate-containing mouthrinse in the control of gingivitis.

AIM: This 4-week, single-centre, randomized, examiner-blind, controlled study investigated the efficacy and safety of 0.15% ethyl lauroyl arginate (LAE)-containing mouthrinse in adults with mild-to-moderate gingivitis. MATERIAL AND METHODS: Subjects were randomized to use 0.15% LAE-containing mouthrinse or 5% hydroalcohol-negative control twice daily after brushing with standard fluoride toothpaste. Plaque, gingivitis and bleeding were assessed at baseline and Weeks 2 and 4. The oral microflora was analysed at baseline and Week 4. RESULTS: Eighty-seven subjects were randomized to treatment. The 0.15% LAE-containing mouthrinse was associated with statistically significantly (p < 0.001) greater reductions in mean plaque and gingivitis scores versus the negative control at Week 2 (difference [95% confidence interval]: plaque 0.83 [0.64, 1.02], 29.1%; gingivitis 0.11 [0.07, 0.14], 4.8%) and Week 4 (co-primary endpoints: plaque 1.23 [1.07, 1.39], 42.6%; gingivitis 0.23 [0.19, 0.28], 10.7%). Bleeding-index scores were significantly (p < 0.001) reduced versus the control at Weeks 2 (by 0.04 [0.03, 0.06], 36.3%) and 4 (by 0.06 [0.04, 0.08], 50.9%). No shifts were detected in the oral microflora. There were no treatment-related adverse events. CONCLUSIONS: The 0.15% LAE-containing mouthrinse was well tolerated and significantly reduced plaque, gingivitis and bleeding when used as an adjunct to tooth brushing for 4 weeks.

Interactions of dentine desensitisers with human dentine: morphology and composition.

OBJECTIVE: To evaluate the effect of desensitising agents on human dentine morphology and composition. METHODS: Randomly assigned human coronal-dentine specimens were subjected to: (a) no treatment (smear-layer control, n=4); (b) acid etching with 6% citric acid (demineralised control, n=4); (c) treatment with desensitising agents (12 cycles of 60 s treatment with 60 s between-treatment rinsing, n=6 per agent); and (d) exposure to acidic challenge (pH 5.0 for 90 s, n=6 per agent). The tested products were: Listerine® Advanced Defence Sensitive (LADS; 1.4% potassium oxalate) mouthrinse, Colgate® Sensitive Pro-Relief™ mouthrinse, and toothpaste slurries (paste/water 1:2 wt/wt ratio) of Colgate® Sensitive Pro-Relief™ paste, Crest® Sensitive paste and Sensodyne® Repair and Protect paste. All dentine surfaces were studied by attenuated total reflectance Fourier transform infrared (ATR-FTIR) spectroscopy, Raman microscopy and high vacuum scanning electron microscopy with energy-dispersive X-ray microanalysis (HV-SEM/EDX). RESULTS: Desensitising slurry treatments occluded tubule orifices of acid-etched dentine, creating a randomly distributed surface pattern of particle aggregates. The greatest intratubular penetration of occluding particles was found in dentine treated with LADS. The atomic ratios of Ca/N and Ca/P, and the mineral/matrix ratios increased after toothpaste-slurry treatments compared with the acid-etched dentine. However, the acidic challenge removed most surface precipitates and further demineralised these substrates. Before the acidic challenge, the surface features were least affected in specimens treated with Sensodyne® Repair and Protect. After the acidic challenge, the sub-surface occlusion features were least affected in specimens treated with LADS. CLINICAL SIGNIFICANCE: Although most tested products achieved occlusion of dentinal tubules and provided evidence of mineral deposits, the deposit formed by LADS demonstrated the greatest resistance to acidic challenge, which simulates intra-oral demineralisation phases.

Consensus Report: 2nd European Workshop on Tobacco Use Prevention and Cessation for Oral Health Professionals.

Tobacco use has been identified as a major risk factor for oral disorders such as cancer and periodontal disease. Tobacco use cessation (TUC) is associated with the potential for reversal of precancer, enhanced outcomes following periodontal treatment, and better periodontal status compared to patients who continue to smoke. Consequently, helping tobacco users to quit has become a part of both the responsibility of oral health professionals and the general practice of dentistry. TUC should consist of behavioural support, and if accompanied by pharmacotherapy, is more likely to be successful. It is widely accepted that appropriate compensation of TUC counselling would give oral health professionals greater incentives to provide these measures. Therefore, TUC-related compensation should be made accessible to all dental professionals and be in appropriate relation to other therapeutic interventions. International and national associations for oral health professionals are urged to act as advocates to promote population, community and individual initiatives in support of tobacco use prevention and cessation (TUPAC) counselling, including integration in undergraduate and graduate dental curricula. In order to facilitate the adoption of TUPAC strategies by oral health professionals, we propose a level of care model which includes 1) basic care: brief interventions for all patients in the dental practice to identify tobacco users, assess readiness to quit, and request permission to re-address at a subsequent visit, 2) intermediate care: interventions consisting of (brief) motivational interviewing sessions to build on readiness to quit, enlist resources to support change, and to include cessation medications, and 3) advanced care: intensive interventions to develop a detailed quit plan including the use of suitable pharmacotherapy. To ensure that the delivery of effective TUC becomes part of standard care, continuing education courses and updates should be implemented and offered to all oral health professionals on a regular basis.